Loading interface...

LEVOTOP-PF 1.5% EYE DROPS

Manufactured byAjanta Pharma Ltd.
ContainsLevofloxacin
Description

LEVOTOP-PF 1.5% EYE DROPS is a broad-spectrum antibiotic used to treat a variety of conditions like Bronchitis, Pneumonia, infections of the bladder, etc. It should be avoided if you are known to be allergic to LEVOTOP-PF 1.5% EYE DROPS or any other fluoroquinolones. This medicine should be used with caution in the elderly population as it increases the risk of Tendinitis and Tendon rupture.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now

Side effects

Major & minor side effects for LEVOTOP-PF 1.5% EYE DROPS

  • Diarrhea
  • Abdominal pain
  • Confusion
  • Fever
  • Redness of skin
  • Change in taste
  • Constipation
  • Dizziness
  • Headache
  • Nausea or vomiting

Uses of LEVOTOP-PF 1.5% EYE DROPS

What is it prescribed for?

  • Cystitis
  • Pyelonephriits
  • Nongonococcal Urethritis
  • Skin and structure Infection
  • Pneumonia
  • Bronchitis
  • Inhalation Anthrax
  • Plague
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The peak effect of this medicine can be observed within 1 to 2 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 24 to 32 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is generally not recommended for use in pregnant women unless absolutely necessary and only under the supervision of a doctor.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary since it may affect the development of the infant's joints. Use only if clearly needed and only under the supervision of a doctor. Close monitoring of the infant for any undesired effects like diarrhoea, diaper rash, etc., is necessary for such cases. Avoid breastfeeding for 4 to 6 hours after a dose to decrease the exposure of the infant to the levofloxacin in breast milk.

Allergy

This medicine is not recommended for use if you have a known allergy to LEVOTOP-PF 1.5% EYE DROPS or any other fluoroquinolones.

Tendinitis or tendon rupture

This medicine is not recommended for use if you have a past history of tendinitis or tendon rupture after using LEVOTOP-PF 1.5% EYE DROPS or any other fluoroquinolones.

Myasthenia gravis

This medicine is not recommended for use if you have a past history of myasthenia gravis or family history of myasthenia gravis (weakness and rapid tiring of muscles which are under voluntary control).
Warnings for special population

Pregnancy

This medicine is generally not recommended for use in pregnant women unless absolutely necessary and only under the supervision of a doctor.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary since it may affect the development of the infant's joints. Use only if clearly needed and only under the supervision of a doctor. Close monitoring of the infant for any undesired effects like diarrhoea, diaper rash, etc., is necessary for such cases. Avoid breastfeeding for 4 to 6 hours after a dose to decrease the exposure of the infant to the levofloxacin in breast milk.
General warnings

Tendinitis and Tendon ruputure

Use of LEVOTOP-PF 1.5% EYE DROPS will increase the risk to develop tendinitis or tendon rupture during the treatment or several months after treatment. This may affect your shoulders, hands, ankles, or other parts of your body. You are at a higher risk if you are more than 60 years of age or if you have undergone a transplant of kidney, heart, or lung. You are also at a higher risk if you are on corticosteroids like dexamethasone, methylprednisolone, or prednisone.

Drug-resistance

Usage of LEVOTOP-PF 1.5% EYE DROPS without sufficient proof or suspicion of a bacterial infection should be avoided. Irrational dosing might fail in providing the benefits and even cause toxicity. It may also increase the risk of development of bacteria that are drug resistant.

Alternative treatment

LEVOTOP-PF 1.5% EYE DROPS can be used to treat acute bacterial exacerbation of chronic bronchitis or uncomplicated cystitis, but only as a last resort. This drug should be used only if you have no alternative treatment options for the above-mentioned conditions.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already the time for your next scheduled dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Escitalopram

Ethinyl Estradiol

Corticosteroids

Quinidine

Aspirin

Antidiabetic drugs

Disease interactions

Central nervous system disorders

This medicine should be used with extreme caution in patients with a history of seizure disorder and other central nervous system abnormalities. Report any incidence of tremors, restlessness, anxiety, confusion, hallucinations, etc., to the doctor on priority. It is advisable to avoid using caffeine-containing products while on therapy with fluoroquinolones.

Colitis

This medicine should be used with extreme caution in patients having a history of gastrointestinal diseases, particularly colitis. Inform your doctor if you have any history of gastrointestinal diseases. Report any incidence of severe diarrhoea, abdominal pain, and blood in stools to the doctor immediately.

QT Prolongation

This medicine should be used with extreme caution in patients with a history of heart diseases and electrolyte disturbances, especially elderly patients. Report any incidence of discomfort in the chest, heart palpitations, etc., to the doctor on priority. Regular cardiac function tests are to be performed if you have any heart disease (arrhythmia) or family history of heart disease.
Food interactions
Information not available.
Lab interactions
Information not available.
Take LEVOTOP-PF 1.5% EYE DROPS with or without food. Do not take in larger amounts than advised. Consult the doctor if you experience any undesirable effects. Do not stop taking LEVOTOP-PF 1.5% EYE DROPS before completion of the course.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
LEVOTOP-PF 1.5% EYE DROPS works by inhibiting an enzyme required for the bacterial DNA to replicate, thus inhibiting bacterial cell division.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Quinolones

Schedule

Schedule H

Levofloxacin: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 20 February 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a697040.html

[Internet]. 2017 [cited 20 February 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/27508#PRODUCTINFO

Levofloxacin (oral) medical facts from Drugs.com [Internet]. Drugs.com. 2017 [cited 20 February 2017]. Available from:

https://www.drugs.com/mtm/levofloxacin.html

Levaquin, Levofloxacin Systemic (levofloxacin) dosing, indications, interactions, adverse effects, and more [Internet]. Reference.medscape.com. 2017 [cited 20 February 2017]. Available from:

http://reference.medscape.com/drug/levaquin-levofloxacin-systemic-levofloxacin-342532#0

TOXNET [Internet]. Toxnet.nlm.nih.gov. 2017 [cited 20 February 2017]. Available from:

https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~vzYyoq:1
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 18 Apr 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.